Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
about
The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune ResponseRestoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosisEndogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral HepatitisPathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitisIL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cellsThe sterile inflammation in the exacerbation of HBV-associated liver injury.Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and SurvivalIL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells.Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infectionElevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma.Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis.Circulating cytokines and histological liver damage in chronic hepatitis B infection.The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.IL33 in rheumatoid arthritis: potencial contribution to pathogenesis.IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in miceInnate lymphoid cells in tissue homeostasis and diseases.Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery.Toll-like receptor-2 exacerbates murine acute viral hepatitis.Ambiguous roles of innate lymphoid cells in chronic development of liver diseases.IL-33/ST2 Axis in Organ FibrosisNLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation
P2860
Q26743383-4337DDB1-8673-4B8B-88FF-09853265585BQ26782048-9A12A4C7-A29E-441D-A4F7-4BFD6C6C9B05Q33760241-D3B84ADC-82D4-4436-AB99-DC61DEC1C6C5Q34994590-870D6652-1181-47BE-B1E6-7FB341B3457FQ35058035-084A5DC7-C2A6-4067-BC19-B676B1854D5EQ35373060-94262D70-04AA-4956-A926-56E7A8950FA9Q35439783-57FA765F-2B07-4D62-BEDD-59F4E2FF7A6DQ35548023-B1E547A1-E15B-4CBB-A04F-3A69223875B3Q35814940-136DBD6B-38CB-4749-88F9-32C961E1C916Q36018196-A5C5091B-067E-45CB-AC4C-A65DFE2C0AC2Q36875021-5C36790A-0DF0-4B1B-9211-0DB0603A2B62Q37001426-B3035DC7-B387-4B70-8D22-E3CF78CB84A4Q37222815-A10EF8E0-CC5D-42DE-BC32-782A46BA7F12Q37300472-F2DCF7CF-A903-4EFB-A62D-D941F93F31BFQ37323553-585450CD-C4CE-430D-A67D-6EE292834A8FQ38068933-F3418A63-8824-4A8B-954D-D231A2BCF82FQ38828462-07E85BE4-9A89-4DBF-A1BF-2484A7B20BCDQ39673177-1CC41F36-DC55-4752-A683-D3180CE8B267Q40063411-E10206D6-9E02-48B8-8266-996F92FB6AF8Q40309219-124F2855-D8F3-45CD-8457-E2B1636D7930Q40641510-B428DDB0-57C2-494F-A211-475440AA15F5Q55208795-92C7605D-EC7B-40F0-BC10-8BE8D27E259EQ58566658-FB2180A3-08FE-423C-A1F1-4F24E42DA819Q58745474-E693EA18-5898-4CEB-9DED-A401537D093B
P2860
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
@ast
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
@en
type
label
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
@ast
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
@en
prefLabel
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
@ast
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
@en
P2093
P2860
P356
P1476
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B
@en
P2093
Desalegn Admassu Ayana
Junyan Feng
Yanfang Jiang
Yanjun Cai
P2860
P304
P356
10.1089/JIR.2011.0109
P577
2012-02-03T00:00:00Z